About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD3.35
- USD3.40
- USD3.29
- USD135.54
- -43.90%
- --
- 217.26k
- 4.77M
- 3M
- 3.06
- -93.40%
Stock News
3 hours ago
Here's How You Can Earn $100 In Passive Income By Investing In Walgreens Boots Alliance Stock
Yahoo
3 hours ago
Databricks says annualized revenue will reach $3.7 billion by next month
CNBC
4 hours ago
Elon Musk's favorability among Republicans dropped 16 points since March, Quinnipiac says
CNBC
4 hours ago
Broadcom: The Best Way To Profit Off The AI Supercycle
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
